News Agency
Men's Weekly

Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

  • Written by PR Newswire
Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout

SINGAPORE and PRINCETON, N.J., Oct. 27, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech developing a novel treatment for gout, today announced the successful completion of an End-of-Phase 2 meeting with US FDA for its...

Read more: Shanton Pharma Completes EOP2 Meeting with US FDA for Refractory Gout Program

How Door-to-Door Private Transfers Simplify Your Ski Trip

Ski holidays might be thrilling, but they're notoriously challenging to arrange. Between booking flights and accommodation, travelers find themselves sorting out equipment, roads less traveled, and the need for a schedule. One added complication that can make or break getting... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion